Hypertension (HTN) is frequently associated with the use of angiogenesis inhibitors targeting the vascular endothelial growth factor (VEGF) pathway and appears to be a generalized effect of this class of agent [8-14]. The gene discussed is VEGFA; the disease is Hypertension.